skip to Main Content

A Look At Latest Figures On R&D For Neglected Diseases

Financing for research and development into so-called neglected diseases – those predominantly affecting lower-income populations – rose recently mainly due to the Ebola outbreak, and private sector contributions represent a bigger share, according to the latest available data from a Gates Foundation-supported database.
Go to Source
Author: Kim Treanor

Back To Top